Related Experiment Video
Updated: Nov 7, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Admission Serum Ionized and Total Calcium as New Predictors of Mortality in Patients with Cardiogenic Shock
Yue Yu1, Jingwen Yu1, Renqi Yao2,3
1Department of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Insights
Low admission serum ionized calcium (iCa) levels predict higher mortality in critically ill patients with cardiogenic shock (CS). This finding highlights iCa as a crucial prognostic marker for CS patients.
Area of Science:
- Cardiology
- Critical Care Medicine
- Clinical Biochemistry
Background:
- Serum calcium is a known mortality predictor across various diseases.
- The prognostic significance of calcium levels in cardiogenic shock (CS) patients is not well-established.
Purpose of the Study:
- To investigate the association between admission serum calcium levels and mortality in critically ill patients with CS.
- To determine if ionized calcium (iCa) or total calcium (tCa) are independent predictors of outcomes in CS.
Main Methods:
- Retrospective analysis of 921 critically ill CS patients from the MIMIC-III database.
- Examined admission serum iCa and tCa levels using restricted cubic spline Cox regression and multivariable Cox analyses.
- Assessed 30-day, 90-day, and 365-day all-cause mortality as study endpoints.
Main Results:
- A nonlinear relationship was observed between serum calcium levels and 30-day mortality (P < 0.001).
- The lowest quartile of serum iCa (Q1: iCa < 1.04 mmol/L) was independently associated with increased 30-day, 90-day, and 365-day mortality compared to the reference quartile (Q3).
- Hazard ratios for Q1 vs. Q3 were 1.35 (30-day), 1.36 (90-day), and 1.28 (365-day).
Conclusions:
- Lower admission serum ionized calcium levels are potential predictors of increased mortality in critically ill patients with cardiogenic shock.
- Serum iCa may serve as a valuable prognostic biomarker for CS patients.
Background:
Although serum calcium has been proven to be a predictor of mortality in a wide range of diseases, its prognostic value in critically ill patients with cardiogenic shock (CS) remains unknown. This retrospective observational study is aimed at investigating the association of admission calcium with mortality among CS patients.
Methods:
Critically ill patients diagnosed with CS in the Medical Information Mart for Intensive Care-III (MIMIC-III) database were included in our study. The study endpoints included 30-day, 90-day, and 365-day all-cause mortalities. First, admission serum ionized calcium (iCa) and total calcium (tCa) levels were analyzed as continuous variables using restricted cubic spline Cox regression models to evaluate the possible nonlinear relationship between serum calcium and mortality. Second, patients with CS were assigned to four groups according to the quartiles (Q1-Q4) of serum iCa and tCa levels, respectively. In addition, multivariable Cox regression analyses were used to assess the independent association of the quartiles of iCa and tCa with clinical outcomes.
Results:
A total of 921 patients hospitalized with CS were enrolled in this study. A nonlinear relationship between serum calcium levels and 30-day mortality was observed (all P values for nonlinear trend < 0.001). Furthermore, multivariable Cox analysis showed that compared with the reference quartile (Q3: 1.11 ≤ iCa < 1.17 mmol/L), the lowest serum iCa level quartile (Q1: iCa < 1.04 mmol/L) was independently associated with an increased risk of 30-day mortality (Q1 vs. Q3: HR 1.35, 95% CI 1.00-1.83, P = 0.049), 90-day mortality (Q1 vs. Q3: HR 1.36, 95% CI 1.03-1.80, P = 0.030), and 365-day mortality (Q1 vs. Q3: HR 1.28, 95% CI 1.01-1.67, P = 0.046) in patients with CS.
Conclusions:
Lower serum iCa levels on admission were potential predictors of an increased risk of mortality in critically ill patients with CS.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Skeleton and Calcium Homeostasis
Serum Studies: Renal Function Tests